Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunome Inc.

8.62
+0.03500.41%
Volume:346.10K
Turnover:2.95M
Market Cap:749.08M
PE:-1.72
High:8.79
Open:8.69
Low:8.35
Close:8.58
Loading ...

Piper says SpringWorks deal suggests Immunome’s varegacestat ‘undervalued’

TIPRANKS
·
28 Apr

Alnylam (ALNY) Moves 8.5% Higher: Will This Strength Last?

Zacks
·
10 Apr

Immunome to Present at the 24th Annual Needham Virtual Healthcare Conference

Business Wire
·
04 Apr

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
04 Apr

Immunome initiated with a Buy at Lake Street

TIPRANKS
·
02 Apr

Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

GlobeNewswire
·
31 Mar

Immunome Executives Make Bold Moves with Major Stock Purchases!

TIPRANKS
·
27 Mar

Closing Bell Movers: GameStop gains 7% on earnings, bitcoin announcement

TipRanks
·
27 Mar

Stock Track | Immunome Inc. Surges 6.19% in Pre-market Following CTO's $103,600 Insider Purchase

Stock Track
·
26 Mar

Stock Track | Immunome Stock Soars 6.33% Following CTO's $103.6K Insider Purchase

Stock Track
·
26 Mar

Stock Track | Immunome Stock Soars 6.33% Following CTO's $103,600 Insider Purchase

Stock Track
·
26 Mar

Stock Track | Immunome Surges 6.04% After Hours Following CTO's $103.6K Stock Purchase

Stock Track
·
26 Mar

Stock Track | Immunome Surges 6.04% After-Hours Following CTO's $103.6K Stock Purchase

Stock Track
·
26 Mar

Immunome CTO buys $103.6K in common stock

TIPRANKS
·
26 Mar

Analysts Offer Insights on Healthcare Companies: Immunome (IMNM), Sanofi (OtherSNYNF) and MacroGenics (MGNX)

TIPRANKS
·
25 Mar

Stock Track | Immunome Plummets 5.08% After Reporting Wider Losses and Missed Estimates for FY 2024

Stock Track
·
22 Mar

Stock Track | Immunome Plummets 5.08% Following Disappointing 2024 Financial Results

Stock Track
·
22 Mar

North American Morning Briefing: Stock Futures Fall as Focus Shifts From Fed to Tariffs

Dow Jones
·
21 Mar

Immunome’s 2024 Financial Results and Pipeline Progress

TIPRANKS
·
21 Mar

Immunome Is Maintained at Buy by Guggenheim

Dow Jones
·
20 Mar